![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 13, 2020 2:37:58 PM
As for the content Patterson and Lalezari are precise with the most important aspect of this investment, the science.
From their lips — Leronlimab is the solution to not only the treatment of Covid-19 but also HIV and the numerous cancer indications. Patterson has drilled down on the MOA and can support his conclusions with science based tests and blood work that leave little room for doubt. I have no question that Letonlimab results are going to blow away Remdesivir, Fauchi’s proclaimed SOC for Covid-19.
Like many I was surprised that we are only at 45 patients in the mild to moderate Covid-19 trial and still needing 30 more for enrollment completion. That was the piece of news that let the air out a bit on the call. If Nader would have said we are a few patients away or fully enrolled the SP would be North of $4 today. Good news is that news is coming in a matter of a couple of weeks. Hopefully the Novant sites will expedite the final 30 patients and we can get to read out by middle of June. Quite frankly that is the missing piece that moves CYDY and Leronlimab to the National and Global exposure we are all clamoring for.
Uplisting is on the radar and will likely coincide with the unblinding of the data on the 75 patient trial. At this point that data is all that matters for blowing the lid off the SP. Positive results will garner a government grant that will unleash the SP and produce an uplist all in a short window. That will be game over in terms of $10 plus SP.
As for our CEO, Nader. The definition of insanity is listening to him present over and over and expect a different result. Having listened to Nader for eight years he has never been a good or even decent presenter. This call was no different.
I have recommended to multiple BOD to gag Nader and let those with the skill set do the presenting. Reality is this is Nader’s paternal baby and he is not going to give up the spotlight. At least he has handed the science off to Patterson and Lalezari to do the presenting. Unfortunately today he should have handed the testimonial he started with to Patterson. The slide show should have also been handed off to the Docs. Behind the scenes Nader is a bulldog that has the SH’s back. In front of the camera he’s a train wreck as Grip has pointed out on too many occasions.
Speaking of Grip - he has sold part of his position. If history is any indication that is a strong buying signal.
Bottom line is the science cannot be stopped and Leronlimab is going to save many lives while producing a slew of millionaires.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM